SIROLIMUS | A208691 | GLENMARK PHARMACEUTICALS LTD
Highest NADAC/Unit
$2.35
per ea
Lowest NADAC/Unit
$0.7127
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68462068401SIROLIMUS 2 MG TABLET | $2.35 | EA | Generic | — | 2026-10-21 |
| 16714018901SIROLIMUS 2 MG TABLET | $2.35 | EA | Generic | — | 2026-10-21 |
| 68462068201SIROLIMUS 0.5 MG TABLET | $0.8326 | EA | Generic | — | 2026-10-21 |
| 16714018701SIROLIMUS 0.5 MG TABLET | $0.8326 | EA | Generic | — | 2026-10-21 |
| 68462068301SIROLIMUS 1 MG TABLET | $0.7127 | EA | Generic | — | 2026-10-21 |
| 16714018801SIROLIMUS 1 MG TABLET | $0.7127 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.